| Specialty Retail Industry | Consumer Discretionary Sector | Facundo Garreton CEO | CNSX Exchange | CA09609Y1016 ISIN |
| CO Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Blueberries Medical Corp. is a leading company engaged in the cultivation, growth, and development of medicinal cannabis, along with its related products, based out of Vancouver, Canada. With its operations rooted in Colombia, the company specializes in the production of both psychoactive and non-psychoactive cannabis-derived products. Its mission is to harness the medicinal properties of cannabis to serve the healthcare sector, leveraging Colombia's ideal cultivation conditions to produce high-quality cannabis at a competitive cost.
These products contain THC, the component known for its psychoactive properties. Blueberries Medical Corp. develops these products for various medical applications, including pain relief, management of chronic conditions, and other therapeutic uses where psychoactive effects are beneficial or can be managed under medical supervision.
In contrast, the company also offers products containing CBD and other non-psychoactive cannabinoids. These products are designed for patients seeking the health benefits of cannabis without the psychoactive effects, suitable for a wide range of conditions like anxiety, inflammation, and epilepsy among others.